Immune checkpoint inhibitors versus second line chemotherapy for patients with lung cancer refractory to first line chemotherapyCaroline Lefèbvre, Julien Mazières, Florent Puisset et al.|Respiratory Medicine and Research|2020Cited by 8
P1.01-120 Immune Checkpoint Inhibitors Versus Second Line Chemotherapy for Patients with Lung Cancer Refractory to First Line ChemotherapyCaroline Lefèbvre, Julien Mazières, E. Martin et al.|Journal of Thoracic Oncology|2019Cited by 1